Nicole A. Borchard Ba
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Nicole A. Borchard Ba has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
Angela Yang
Division of Rhinology, Department of Otolaryngology – Head and Neck Surgery Stanford University School of Medicine Palo Alto California U.S.A.
1 shared publicationAshoke Khanwalkar
Division of Rhinology, Department of Otolaryngology – Head and Neck Surgery Stanford University School of Medicine Palo Alto California U.S.A.
1 shared publicationDayoung Kim
Division of Rhinology, Department of Otolaryngology – Head and Neck Surgery Stanford University School of Medicine Palo Alto California U.S.A.
1 shared publication- Jayakar V. Nayak
Department of Otolaryngology, Head and Neck Surgery Stanford University School of Medicine Stanford California USA
1 shared publication Matt Lechner
Division of Rhinology, Department of Otolaryngology – Head and Neck Surgery Stanford University School of Medicine Palo Alto California U.S.A.
1 shared publication- Michael T. Chang
Department of Otolaryngology–Head and Neck Surgery Stanford University School of Medicine Stanford California USA
1 shared publication
Latest Publications
- 15 May 2021
- Published by Wiley in The Laryngoscope
- Vol. 131 (11) , E2736-E2741
Long‐Term Outcomes of Inferior Meatus Augmentation Procedure to Treat Empty Nose Syndrome
Objectives/Hypothesis: We sought to report the long‐term, symptom‐focused, prospective outcomes in empty nose syndrome (ENS) patients after undergoing inferior meatus augmentation procedure (IMAP) through use of four validated questionnaires: Empty Nose Syndrome 6‐Item Questionnaire (ENS6Q), 22‐item Sino‐Nasal Outcome Test (SNOT‐22), Generalized Anxiety Disorder 7‐Item Scale (GAD‐7), and Patient Health Questionnaire‐9 (PHQ‐9).Study Design: Prospective case series.Methods: A single‐center prospective case series was performed for patients diagnosed with ENS who underwent IMAP between July 2017 and February 2020. Diagnosis of ENS was based on the following criteria: 1) reported discomfort with nasal breathing and/or paradoxical nasal obstruction after inferior turbinate reduction, 2) a positive ENS6Q score of at least 11, and 3) a positive cotton test. Questionnaire responses were recorded prior to surgery as well as 1, 3, 6, and 12 months postoperatively.Results: Seventeen eligible patients were included. Mean ENS6Q scores were significantly reduced at all postoperative time points (p < .0001, p < .0001, p < .0001, p = .0003). Of the six ENS6Q subdomains, five (suffocation, dryness, sense of diminished airflow, nasal crusting, and nasal burning) were significantly reduced 1‐year postoperatively (p < .0001, p = .0004, p = .0136, p = .0114, p = .0080, respectively). SNOT‐22 scores were significantly reduced at all time points (p = .0021, p = .0227, p = .0004, and p = .0025). Of the SNOT‐22 subdomains, the sleep subdomain was significantly reduced 1‐year postoperatively (p = .0432). Low baseline GAD‐7 and PHQ‐9 scores were recorded at 7 and 9.4, respectively, and although scores at all postoperative time points were reduced, there was no statistical significance.Conclusion: IMAP via implant of cadaveric rib cartilage provides significant, long‐term improvements in ENS‐specific and general sinonasal symptoms.Level of Evidence: 4 Laryngoscope, 131:E2736–E2741, 2021
- 15 May 2021
- Published by Wiley in The Laryngoscope
- Vol. 131 (11) , E2736-E2741
Long‐Term Outcomes of Inferior Meatus Augmentation Procedure to Treat Empty Nose Syndrome
Objectives/Hypothesis: We sought to report the long‐term, symptom‐focused, prospective outcomes in empty nose syndrome (ENS) patients after undergoing inferior meatus augmentation procedure (IMAP) through use of four validated questionnaires: Empty Nose Syndrome 6‐Item Questionnaire (ENS6Q), 22‐item Sino‐Nasal Outcome Test (SNOT‐22), Generalized Anxiety Disorder 7‐Item Scale (GAD‐7), and Patient Health Questionnaire‐9 (PHQ‐9).Study Design: Prospective case series.Methods: A single‐center prospective case series was performed for patients diagnosed with ENS who underwent IMAP between July 2017 and February 2020. Diagnosis of ENS was based on the following criteria: 1) reported discomfort with nasal breathing and/or paradoxical nasal obstruction after inferior turbinate reduction, 2) a positive ENS6Q score of at least 11, and 3) a positive cotton test. Questionnaire responses were recorded prior to surgery as well as 1, 3, 6, and 12 months postoperatively.Results: Seventeen eligible patients were included. Mean ENS6Q scores were significantly reduced at all postoperative time points (p < .0001, p < .0001, p < .0001, p = .0003). Of the six ENS6Q subdomains, five (suffocation, dryness, sense of diminished airflow, nasal crusting, and nasal burning) were significantly reduced 1‐year postoperatively (p < .0001, p = .0004, p = .0136, p = .0114, p = .0080, respectively). SNOT‐22 scores were significantly reduced at all time points (p = .0021, p = .0227, p = .0004, and p = .0025). Of the SNOT‐22 subdomains, the sleep subdomain was significantly reduced 1‐year postoperatively (p = .0432). Low baseline GAD‐7 and PHQ‐9 scores were recorded at 7 and 9.4, respectively, and although scores at all postoperative time points were reduced, there was no statistical significance.Conclusion: IMAP via implant of cadaveric rib cartilage provides significant, long‐term improvements in ENS‐specific and general sinonasal symptoms.Level of Evidence: 4 Laryngoscope, 131:E2736–E2741, 2021